One of the common serological hallmarks of autoimmune disorders is the presence of various autoantibodies in the sera of patients affected by these disorders. Antinuclear antibodies (ANA) detection is often needed to aid the diagnosis in several autoimmune disorders. In view of the different methodologies available for their detection, it becomes essential to understand the advantages and pitfalls of each procedure. This brief review discusses some methodological aspects of ANA detection and the clinical relevance of the presence of some of the autoantibodies found in the sera of patients with autoimmune disorders
Objective: In neurological clinical practice screening test for ANA (Anti-nuclear antibody) is helpf...
AbstractIntroduction: Determination of antinuclear antibodies (ANA) by indirect immunofluorescence (...
Abstract The production of anti-nuclear antibody (ANA) can be observed, more commonly, in the contex...
One of the common serological hallmarks of autoimmune disorders is the presence of various autoantib...
The presence of various autoantibodies in patients' sera is the most common marker of autoimmune dis...
Autoantibodies are frequently determined in unclear clinical situations and in the context of an inf...
Background: Anti-nuclear autoantibodies (ANA), have explicitly been linked to immune complex-mediate...
Aim: To determine the positivity and prevalence of ANA in various autoimmune diseases in children. ...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
The impact of autoimmune diseases is growing from both a clinical and a laboratory point of view. Di...
The appearance of biologic agents for the treatment of diverse autoimmune diseases in particular rhe...
Introduction: Determination of antinuclear antibodies (ANA) by indirect immunofluorescence (IIF) is ...
WOS: 000323802900015Objective: In neurological clinical practice screening test for ANA (Anti-nuclea...
Objective: In neurological clinical practice screening test for ANA (Anti-nuclear antibody) is helpf...
Objective: Aim of this study is to evaluate anti-nuclear antibody (ANA) test results obtained betwee...
Objective: In neurological clinical practice screening test for ANA (Anti-nuclear antibody) is helpf...
AbstractIntroduction: Determination of antinuclear antibodies (ANA) by indirect immunofluorescence (...
Abstract The production of anti-nuclear antibody (ANA) can be observed, more commonly, in the contex...
One of the common serological hallmarks of autoimmune disorders is the presence of various autoantib...
The presence of various autoantibodies in patients' sera is the most common marker of autoimmune dis...
Autoantibodies are frequently determined in unclear clinical situations and in the context of an inf...
Background: Anti-nuclear autoantibodies (ANA), have explicitly been linked to immune complex-mediate...
Aim: To determine the positivity and prevalence of ANA in various autoimmune diseases in children. ...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
The impact of autoimmune diseases is growing from both a clinical and a laboratory point of view. Di...
The appearance of biologic agents for the treatment of diverse autoimmune diseases in particular rhe...
Introduction: Determination of antinuclear antibodies (ANA) by indirect immunofluorescence (IIF) is ...
WOS: 000323802900015Objective: In neurological clinical practice screening test for ANA (Anti-nuclea...
Objective: In neurological clinical practice screening test for ANA (Anti-nuclear antibody) is helpf...
Objective: Aim of this study is to evaluate anti-nuclear antibody (ANA) test results obtained betwee...
Objective: In neurological clinical practice screening test for ANA (Anti-nuclear antibody) is helpf...
AbstractIntroduction: Determination of antinuclear antibodies (ANA) by indirect immunofluorescence (...
Abstract The production of anti-nuclear antibody (ANA) can be observed, more commonly, in the contex...